- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04219930
Nucleotide Protein -3 in Epileptic Children
Biochemical Role of Nucleotide Protein -3 That Activate the Interleukin-1B in Epileptic Children
Epilepsy is one of common serious neurological malfunction, characterized by recurrent unprovoked seizures. It always accompanied with multitude of complications as cognitive, behavioral, and psychiatric disorders.
Experimental studies and clinical evidence obtained in animal models of epilepsy and human brain specimen from various drug-resistant forms of epilepsy show the activation of the innate and adaptive immunity mechanisms and the induction of the associated inflammatory processes in the epileptogenic foci.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Epilepsy affects approximately 1% of the world population. Lifetime prevalence of childhood and adolescence epilepsy (children <18 years) in Upper Egypt was 9.7/1000, with higher prevalence among children <12 years (10.8/1000).
There is a clear cause for epilepsy in only a minority of the cases, while in up to70% of all case of epilepsy in adults and children, no cause can be discovered. Some of the main causes of epilepsy include: Low oxygen during birth, head injuries that occur during birth or from accidents during youth or adulthood, brain tumors, infections such as meningitis or encephalitis, stroke or any other type of damage to the brain.
A role of inflammatory molecules in the generation of seizures had been first investigated when selected anti-inflammatory treatments, in particular, steroids, immuno-globulins, and adrenocorticotropic hormone (ACTH), were shown to control seizures in pediatric epilepsies refractory to conventional anticonvulsive drugs. In addition, specific epileptic disorders have been associated with the presence of neuronal antigen-directed antibodies in plasma or cerebrospinal fluid (CSF).
A nucleotide-binding oligomerization domains (NODs) are cytosolic proteins that include key regulators of apoptosis and pathogen resistance in mammals and plants. A large number of NODs contain leucine-rich repeats (LRRs), hence referred to as NOD-LRR proteins. The NLRP3 gene provides instructions for making a protein called cryopyrin. Cryopyrin is a member of a family of proteins called nucleotide-binding domain and leucine-rich repeat containing (NLR) proteins. NLR family have two common features: the first is a nucleotide-binding oligomerization domain which is bound by ribonucleotide-phosphates (rNTP) and is important for self-oligomerization. The second is a C-terminal leucine-rich repeat, which serves as a ligand-recognition domain for other receptors (e.g. Toll like receptor (TLR)) or microbial ligands, while NLRP3 has been identified in microglial cells.
Undersøgelsestype
Tilmelding (Forventet)
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Epileptic children in Assiut university hospital, pediatric department, neurology unit.
Exclusion Criteria:
- Children with other chronic disease such as liver, kidney or heart disease
- patient who have apparent infection
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
epileptic children
fifty patient with epilepsy
|
Expression of nucleotide protein -3 will be measured in serum by ELISA
|
Healthy controls
thirty healthy control
|
Expression of nucleotide protein -3 will be measured in serum by ELISA
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
The mean difference of nucleotide protein -3 inflammatory marker expression in epileptic children and controls
Tidsramme: Baseline
|
better understanding the role of inflammation in pathogenesis of epilepsy in children
|
Baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Generelle publikationer
- He Q, Jiang L, Man S, Wu L, Hu Y, Chen W. Curcumin Reduces Neuronal Loss and Inhibits the NLRP3 Inflammasome Activation in an Epileptic Rat Model. Curr Neurovasc Res. 2018;15(3):186-192. doi: 10.2174/1567202615666180731100224.
- Farghaly WM, Abd Elhamed MA, Hassan EM, Soliman WT, Yhia MA, Hamdy NA. Prevalence of childhood and adolescence epilepsy in Upper Egypt (desert areas). Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):34. doi: 10.1186/s41983-018-0032-0. Epub 2018 Nov 9.
- Xu D, Miller SD, Koh S. Immune mechanisms in epileptogenesis. Front Cell Neurosci. 2013 Nov 8;7:195. doi: 10.3389/fncel.2013.00195. eCollection 2013.
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Epilepsy
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Epilepsi hos børn
-
Meshalkin Research Institute of Pathology of CirculationIkke rekrutterer endnustyrkeegenskaberne for aorta in vivo | aortaens styrkeegenskaber in vitro | Regressionsmodel af aortastyrkeegenskaber in vitro og in vitroDen Russiske Føderation
-
Organon and CoAfsluttet
-
Boston Scientific CorporationAktiv, ikke rekrutterende
-
Centre Hospitalier Universitaire de NīmesAfsluttet
-
Kaohsiung Veterans General Hospital.Afsluttet
-
Kaohsiung Veterans General Hospital.Afsluttet
-
Adiyaman UniversityAfsluttet
-
Rabin Medical CenterUkendt
-
Istituto Clinico HumanitasAfsluttet
-
Suleyman Demirel UniversityUkendtin vitro befrugtningKalkun
Kliniske forsøg med Expression of nucleotide protein -3
-
KU LeuvenAfsluttetSunde og akut syge børn og voksneBelgien
-
Rigshospitalet, DenmarkNational Center of Cardiology and Internal Medicine named after academician... og andre samarbejdspartnereAfsluttetLuftvejsinfektioner | Antibiotikaresistens | Pædiatrisk infektionssygdom | CRPKirgisistan
-
Herlev and Gentofte HospitalNutricia, Inc.RekrutteringRehabilitering | Orale kosttilskud | Ernæringsmæssig risikoDanmark
-
Liverpool School of Tropical MedicineIkke rekrutterer endnuTuberkulose | Diagnose
-
Duke UniversityAfsluttetIntrakraniel hypertension | Cerebrovaskulær ulykkeForenede Stater
-
Giancarlo NatalucciIkke rekrutterer endnu
-
Musclegen Research, Inc.WakeMed Bariatric Surgery & Weight Loss CenterUkendtProteinintolerance | Protein malabsorption | Absorption; Lidelse, ProteinForenede Stater
-
Samsung Medical CenterRekrutteringTredobbelt negativ brystkræft | Immun Checkpoint InhibitorKorea, Republikken
-
University Hospital, Basel, SwitzerlandRekrutteringNSTEMI - Ikke-ST Segment Elevation MI | Akutte brystsmerterDet Forenede Kongerige, Schweiz, Spanien, Korea, Republikken, Forenede Stater, Australien, Østrig, Finland, Grækenland, Italien, Rumænien
-
Northwestern UniversityFriends of PrenticeAktiv, ikke rekrutterendeFor tidlig fødsel | For tidligt spædbarn | NICUForenede Stater